177 results Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Philippe Campolini authored the Belgian chapter of EPO's country-by-country overview on patent enforcement in Europe The European Patent Academy, along with authors across Europe, presents a comprehensive guide on patent enforcement across 38 EPC states. Discover measures to safeguard patent rights and relevant national procedures in this harmonization effort. Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL). Origin of the primary ingredient - Implementing Regulation 2018/775 European Regulation 1169/2011 now mandates clear indication of primary ingredient origin when it differs from the product's origin. Enhancing food information for consumers. Online marketplace's liability for trademark infringement While online shopping is booming in such period of COVID-19 outbreak, the Court of Justice of the EU (CJEU) recently decided that Amazon cannot be accused of trade mark infringement. Philippe Campolini co-authored a book dedicated to the protection of trade secrets in Belgium The book, entitled 'Secrets d'Affaires' explores the EU Trade Secrets Directive and its implementation in Belgian law, covering key concepts, lawful/unlawful acts, contract implications, and trade secret protection in administrative law. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Heineken Stibbe advises Heineken on its strategic partnership agreement with Sligro Food Group. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises Tata Communications on the acquisition of Teleena Stibbe advises Tata Communications, a leading global digital infrastructure provider, on the acquisition of Teleena, a Netherlands-based Internet of Things (IoT) connectivity specialist and mobile virtual network enabler (MVNE). Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Pagination Previous page Page 3 Current page 4 Page 5 Page 6 Next page
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.
Philippe Campolini authored the Belgian chapter of EPO's country-by-country overview on patent enforcement in Europe The European Patent Academy, along with authors across Europe, presents a comprehensive guide on patent enforcement across 38 EPC states. Discover measures to safeguard patent rights and relevant national procedures in this harmonization effort.
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).
Origin of the primary ingredient - Implementing Regulation 2018/775 European Regulation 1169/2011 now mandates clear indication of primary ingredient origin when it differs from the product's origin. Enhancing food information for consumers.
Online marketplace's liability for trademark infringement While online shopping is booming in such period of COVID-19 outbreak, the Court of Justice of the EU (CJEU) recently decided that Amazon cannot be accused of trade mark infringement.
Philippe Campolini co-authored a book dedicated to the protection of trade secrets in Belgium The book, entitled 'Secrets d'Affaires' explores the EU Trade Secrets Directive and its implementation in Belgian law, covering key concepts, lawful/unlawful acts, contract implications, and trade secret protection in administrative law.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Heineken Stibbe advises Heineken on its strategic partnership agreement with Sligro Food Group.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises Tata Communications on the acquisition of Teleena Stibbe advises Tata Communications, a leading global digital infrastructure provider, on the acquisition of Teleena, a Netherlands-based Internet of Things (IoT) connectivity specialist and mobile virtual network enabler (MVNE).
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.